Featuring contributions from nearly 30 leading authorities, this pioneering work gauges the potential for viruses to act as oncolytic and anti-tumor agents for the treatment of cancers in humans-detailing the cancer-combative properties exhibited by viruses in nature, genetically engineered viruses, and viral oncolysates as evidenced in basic and experimental studies.
Featuring contributions from leading authorities, this pioneering work explores the potential for viruses to act as oncolytic and anti-tumor agents for the treatment of cancers. It details the cancer-combative properties exhibited by viruses in nature, genetically engineered viruses, and viral oncolysates as evidenced in basic and experimental studies and includes coverage of measles, influenza, and herpes simplex viruses; parvoviruses; poliovirus recombinants; Newcastle disease viruses and viral oncolysates; and vaccinia viral lysates. Comparing the viral therapy of cancer with alternative biological therapeutic approaches, the book lists more than fifty oncolytic adenovirus preparations.
